Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
PP 2 (AG 1879): Reliable Src Assay Design
2026-08-19
A scenario-based guide to using PP 2 (AG 1879), SKU A8216, in cell proliferation, viability, cytotoxicity, and signal-transduction workflows. It connects biochemical selectivity, solvent handling, concentration interpretation, and vendor-selection criteria to practical laboratory decisions.
-
Pexidartinib (PLX3397) for TAM Assays
2026-08-19
Use Pexidartinib (PLX3397) as a controlled CSF1R perturbation tool to separate macrophage survival effects from direct tumor-cell responses. This workflow pairs CSF1R-mediated signaling inhibition with SPP1-focused phenotyping, enabling clearer interpretation of tumor microenvironment macrophage modulation in translational cancer research.
-
0.4% Trypan Blue Solution: Practical Cell Counting
2026-08-18
0.4% Trypan Blue Solution provides a simple endpoint method for cell viability measurement, cell counting, and live/dead cell discrimination in research cell suspensions. It is intended for scientific research workflows such as culture monitoring and cytotoxicity assays, but it should not be used as a diagnostic, medical, or standalone apoptosis and necrosis detection test.
-
Thioredoxin Control of CHK1 Inhibitor Sensitivity
2026-08-18
The reference study identifies thioredoxin 1 as a determinant of checkpoint kinase 1 inhibitor sensitivity in non-small cell lung cancer. Its key mechanistic contribution is linking thioredoxin-dependent redox recycling of RRM1, ribonucleotide reductase activity, and deoxynucleotide availability, providing a rationale for combining CHK1 inhibitors with thioredoxin reductase inhibition.
-
Palmitic Acid: Protocol and QC Guide
2026-08-17
Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a characterized saturated long-chain fatty acid for controlled non-aqueous supplementation and lipid-focused research. It is suitable for metabolic, inflammatory, and signaling workflows when solvent controls and fresh preparations are used, but it is not appropriate for aqueous protocols or long-term solution storage.
-
HOXC8, Caspase-1, and Pyroptosis in Lung Cancer
2026-08-17
The reference study identifies HOXC8 as a transcriptional suppressor of CASP1 that protects non-small cell lung carcinoma cells from caspase-1-driven pyroptosis. Its key contribution is linking HOXC8 to HDAC1/2 recruitment at the CASP1 promoter, providing a mechanistic explanation for how a developmental transcription factor can influence tumor cell survival and lung tumorigenesis.
-
15-PGDH Inhibition Supports Muscle Repair in Weight Loss
2026-08-16
A 2026 PNAS study identifies 15-PGDH inhibition as a strategy for improving muscle regeneration and force recovery during semaglutide-associated weight loss in obese mice. The work shows that combining a 15-PGDH inhibitor with semaglutide can improve postinjury muscle quality without negating weight-loss efficacy.
-
TAK-242 (Resatorvid) TLR4 Workflow Guide
2026-08-15
Learn how to use TAK-242 as a mechanistic probe in LPS-challenged macrophages, NET–endothelial co-cultures, and neuroinflammation research. This guide emphasizes dosing logic, pathway-specific controls, assay timing, and troubleshooting for reproducible inflammatory signal pathway suppression.
-
Sunitinib Beyond Angiogenesis: Metabolic Resensitization
2026-08-14
Sunitinib research is moving beyond vessel blockade toward adaptive-state biology. This thought-leadership analysis shows how metabolic intervention, causal rescue experiments, and biomarker-aligned workflows can clarify resistance in renal cell carcinoma models.
-
Foretinib (GSK1363089) for Mechanism-Resolved Assays
2026-08-14
Foretinib (GSK1363089) is a potent ATP-competitive multikinase inhibitor for dissecting tumor cell growth, motility, invasion, and metastasis. This article applies endpoint-aware assay logic from cancer pharmacology research to help distinguish cytostatic effects from genuine cell killing.
-
JC-1 Mitochondrial Membrane Potential Assay Kit Guide
2026-08-13
Turn mitochondrial depolarization into a practical, ratiometric readout for apoptosis assay design, drug screening, and mitochondrial function analysis. This workflow shows how to pair the JC-1 assay with phototherapy and DNA-damage studies while controlling dye, cell-density, and imaging variables.
-
FLIPinB and S63845 in Pancreatic Cancer Apoptosis
2026-08-13
The reference study shows that pharmacologically targeting the caspase-8/c-FLIPL heterodimer with FLIPinB strengthens death-ligand responses when combined with gemcitabine and the MCL1 inhibitor S63845. Its central mechanistic contribution is linking this drug combination to enhanced complex II assembly, providing a rationale for coordinated activation of extrinsic and mitochondrial apoptosis in pancreatic cancer cells.
-
Primidone, RIPK1, and ALS Biomarker Evidence
2026-08-12
The reference study links peripheral RIPK1 and IL-8 measurements with disease features in amyotrophic lateral sclerosis (ALS) while testing Primidone as a repurposed RIPK1-inhibitory intervention. Its combination of SOD1G93A mouse experiments and a 24-week patient study supports biomarker development, but does not yet establish that serum signals directly measure central nervous system target engagement or clinical efficacy.
-
Caspase-4 Colorimetric Assay Kit for Pyroptosis
2026-08-12
Translate inflammatory signaling into a quantitative LEVD-dependent caspase-4 readout while investigating how ER-targeted peptide assemblies alter cancer cell fate. This workflow pairs a fast colorimetric caspase assay with orthogonal measures of ER stress, cell death, and pyroptosis.
-
Lipo3K Transfection Reagent: Practical Cell Workflows
2026-08-11
Lipo3K Transfection Reagent combines high nucleic acid delivery with a low-toxicity workflow for adherent, suspension, and difficult-to-transfect cells. This guide connects practical DNA, siRNA, mRNA, and co-transfection strategies with a pH-responsive antisense oligonucleotide study, helping researchers choose controls, timing, and troubleshooting steps more confidently.